Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/chapter/10.1007/978-3-319-04843-7_2.

Title:
Wnt Signaling in Osteosarcoma | SpringerLink
Description:
Osteosarcoma (OS) is the most common primary bone malignancy diagnosed in children and adolescents with a high propensity for local invasion and distant metastasis. Despite current multidisciplinary treatments, there has not been a drastic change in overall prognosis...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {šŸ”}

pubmed, google, scholar, article, cas, cancer, wnt, signaling, osteosarcoma, cell, pathway, cells, central, res, wntbetacatenin, biol, chapter, human, hoang, tumor, protein, stem, betacatenin, wntβcatenin, secreted, inhibitory, clin, current, lin, role, development, rev, dev, chem, factor, privacy, cookies, content, data, information, publish, research, advances, chen, metastasis, disease, wif, sclerostin, small, access,

Topics {āœ’ļø}

wnt-5a/ca2 + -induced nfat activity noncanonical wnt/β-catenin agonists inactive wnt/beta-catenin pathway antagonize wnt/beta-catenin signaling beta-catenin-independent wnt signaling wnt/beta-catenin signaling pathway beta-catenin/tcf signaling pathway beta-catenin-independent pathways wnt/β-catenin signaling month download article/chapter wnt/beta-catenin pathway wnt-beta-catenin pathway wnt/beta-catenin signaling beta-catenin-tcf signaling beta-catenin/tcf signaling beta-catenin binding domain wnt/beta-catenin antagonists beta-catenin-tcf complex nonsteroidal anti-inflammatory drugs cheng-fong chenĀ &Ā bang her2/neu mouse model small molecule-mediated disruption beta-catenin signalling blocking wnt/lrp5 signaling wnt/β-catenin conventional high-grade osteosarcoma tissue/planar cell polarity activator β-catenin beta-catenin signaling frizzled/pcp signalling soluble receptor modulates wnt-dependent signaling istituto ortopedico rizzoli beta-catenin caught wnt signaling pathway suppresses tumorigenic potential wnt5a/ror2 signaling inhibits tumor growth privacy choices/manage cookies exhibits biological activity anti-tumor effects wnt inhibitory protein small molecule inhibitor device instant download wnt inhibitory factor-1 β-catenin human osteosarcoma cells wnt signaling expressed wnt-1 signaling leads alternative wnt signaling

Questions {ā“}

  • Luo J et al (2007) Wnt signaling and human diseases: what are the therapeutic implications?
  • Takahashi-Yanaga F, Kahn M (2010) Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Schema {šŸ—ŗļø}

ScholarlyArticle:
      headline:Wnt Signaling in Osteosarcoma
      pageEnd:45
      pageStart:33
      image:https://media.springernature.com/w153/springer-static/cover/book/978-3-319-04843-7.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Current Advances in Osteosarcoma
         isbn:
            978-3-319-04843-7
            978-3-319-04842-0
         type:Book
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Carol H. Lin
            affiliation:
                  name:CHOC Children’s Hospital
                  address:
                     name:The Hyundai Cancer Institute, CHOC Children’s Hospital, Orange, USA
                     type:PostalAddress
                  type:Organization
                  name:University of California
                  address:
                     name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tao Ji
            affiliation:
                  name:University of California
                  address:
                     name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
                     type:PostalAddress
                  type:Organization
                  name:Peking University
                  address:
                     name:Musculoskeletal Tumor Center, People’s Hospital, Peking University, Beijing, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cheng-Fong Chen
            affiliation:
                  name:University of California
                  address:
                     name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
                     type:PostalAddress
                  type:Organization
                  name:Taipei Veterans General Hospital
                  address:
                     name:Department of Orthopaedics, Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bang H. Hoang
            affiliation:
                  name:University of California
                  address:
                     name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      keywords:Osteosarcoma, Wnt, β-Catenin, Dickkopf, Wnt inhibitory protein, Frizzled-related proteins
      description:Osteosarcoma (OS) is the most common primary bone malignancy diagnosed in children and adolescents with a high propensity for local invasion and distant metastasis. Despite current multidisciplinary treatments, there has not been a drastic change in overall prognosis within the last two decades. With current treatments, 60–70 % of patients with localized disease survive. Given a propensity of Wnt signaling to control multiple cellular processes, including proliferation, cell fate determination, and differentiation, it is a critical pathway in OS disease progression. At the same time, this pathway is extremely complex with vast arrays of cross-talk. Even though decades of research have linked the role of Wnt to tumorigenesis, there are still outstanding areas that remain poorly understood and even controversial. The canonical Wnt pathway functions to regulate the levels of the transcriptional co-activator β-catenin, which ultimately controls key developmental gene expressions. Given the central role of this mediator, inhibition of Wnt/β-catenin signaling has been investigated as a potential strategy for cancer control. In OS, several secreted protein families modulate the Wnt/β-catenin signaling, including secreted Frizzled-related proteins (sFRPs), Wnt inhibitory protein (WIF), Dickkopf proteins (DKK-1,2,3), sclerostin, and small molecules. This chapter focuses on our current understanding of Wnt/β-catenin signaling in OS, based on recent in vitro and in vivo data. Wnt activates noncanonical signaling pathways as well that are independent of β-catenin which will be discussed. In addition, stem cells and their association with Wnt/β-catenin are important factors to consider. Ultimately, the multiple canonical and noncanonical Wnt/β-catenin agonists and antagonists need to be further explored for potential targeted therapies.
      datePublished:2014
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Current Advances in Osteosarcoma
      isbn:
         978-3-319-04843-7
         978-3-319-04842-0
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:CHOC Children’s Hospital
      address:
         name:The Hyundai Cancer Institute, CHOC Children’s Hospital, Orange, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
         type:PostalAddress
      name:Peking University
      address:
         name:Musculoskeletal Tumor Center, People’s Hospital, Peking University, Beijing, People’s Republic of China
         type:PostalAddress
      name:University of California
      address:
         name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
         type:PostalAddress
      name:Taipei Veterans General Hospital
      address:
         name:Department of Orthopaedics, Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital, Taipei, Taiwan
         type:PostalAddress
      name:University of California
      address:
         name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Carol H. Lin
      affiliation:
            name:CHOC Children’s Hospital
            address:
               name:The Hyundai Cancer Institute, CHOC Children’s Hospital, Orange, USA
               type:PostalAddress
            type:Organization
            name:University of California
            address:
               name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
               type:PostalAddress
            type:Organization
      name:Tao Ji
      affiliation:
            name:University of California
            address:
               name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
               type:PostalAddress
            type:Organization
            name:Peking University
            address:
               name:Musculoskeletal Tumor Center, People’s Hospital, Peking University, Beijing, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Cheng-Fong Chen
      affiliation:
            name:University of California
            address:
               name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
               type:PostalAddress
            type:Organization
            name:Taipei Veterans General Hospital
            address:
               name:Department of Orthopaedics, Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      name:Bang H. Hoang
      affiliation:
            name:University of California
            address:
               name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:The Hyundai Cancer Institute, CHOC Children’s Hospital, Orange, USA
      name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
      name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
      name:Musculoskeletal Tumor Center, People’s Hospital, Peking University, Beijing, People’s Republic of China
      name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
      name:Department of Orthopaedics, Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital, Taipei, Taiwan
      name:Department of Orthopaedic Surgery and Chao Family Comprehensive Cancer Center, University of California, Orange, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(314)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • AOS
  • Clipboard.js

CDN Services {šŸ“¦}

  • Pbgrd

5.54s.